American Century Companies Inc United Therapeutics Corp Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, American Century Companies Inc holds 50,151 shares of UTHR stock, worth $18.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

50,151

Previous 41,233 21.63%

Holding current value

$18.6 Million

Previous $13.1 Million 36.83%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$311.04 - $363.55 $2.77 Million - $3.24 Million	8,918 Added 21.63%	50,151 $18 Million
Q2 2024 Aug 07, 2024	BUY	$228.26 - $319.04 $2.82 Million - $3.94 Million	12,360 Added 42.81%	41,233 $13.1 Million
Q1 2024 May 14, 2024	BUY	$210.76 - $249.51 $2.11 Million - $2.49 Million	9,999 Added 52.98%	28,873 $6.63 Million
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $4.06 Million - $4.85 Million	18,874 New	18,874 $4.15 Million
Q3 2023 Nov 13, 2023	BUY	$211.82 - $248.24 $228,130 - $267,354	1,077 Added 6.45%	17,762 $4.01 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $16.9 Million - $19.2 Million	-82,576 Reduced 83.19%	16,685 $3.68 Million
Q1 2023 May 11, 2023	BUY	$212.99 - $276.17 $17.8 Million - $23.1 Million	83,477 Added 528.87%	99,261 $22.2 Million
Q4 2022 Feb 13, 2023	BUY	$205.95 - $280.43 $637,827 - $868,491	3,097 Added 24.41%	15,784 $4.39 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $32.8 Million - $39.4 Million	-161,378 Reduced 92.71%	12,687 $2.66 Million
Q2 2022 Aug 12, 2022	BUY	$174.81 - $241.14 $18.3 Million - $25.2 Million	104,569 Added 150.47%	174,065 $41 Million
Q1 2022 May 11, 2022	BUY	$166.16 - $213.96 $10.4 Million - $13.4 Million	62,576 Added 904.28%	69,496 $12.5 Million
Q4 2021 Feb 07, 2022	SELL	$184.32 - $216.08 $947,404 - $1.11 Million	-5,140 Reduced 42.62%	6,920 $1.5 Million
Q3 2021 Nov 10, 2021	BUY	$179.86 - $214.88 $951,639 - $1.14 Million	5,291 Added 78.17%	12,060 $2.23 Million
Q2 2021 Aug 05, 2021	BUY	$170.47 - $211.93 $90,690 - $112,746	532 Added 8.53%	6,769 $1.21 Million
Q1 2021 May 14, 2021	BUY	$153.94 - $174.85 $236,297 - $268,394	1,535 Added 32.65%	6,237 $1.04 Million
Q4 2020 Feb 12, 2021	BUY	$101.87 - $151.79 $56,232 - $83,788	552 Added 13.3%	4,702 $714,000
Q3 2020 Nov 13, 2020	BUY	$99.9 - $121.13 $28,271 - $34,279	283 Added 7.32%	4,150 $419,000
Q2 2020 Aug 13, 2020	BUY	$92.74 - $125.82 $358,625 - $486,545	3,867 New	3,867 $468,000
Q2 2018 Aug 08, 2018	SELL	$101.14 - $118.31 $759,864 - $888,863	-7,513 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$107.21 - $151.94 $675,744 - $957,677	-6,303 Reduced 45.62%	7,513 $844,000
Q4 2017 Feb 02, 2018	SELL	$118.58 - $151.28 $232,772 - $296,962	-1,963 Reduced 12.44%	13,816 $2.04 Million
Q3 2017 Nov 01, 2017	BUY	$114.6 - $136.81 $1.81 Million - $2.16 Million	15,779	15,779 $1.85 Million

Others Institutions Holding UTHR

# of Institutions

679

Shares Held

42.1M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.9B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc United Therapeutics Corp Transaction History